Log in to save to my catalogue

Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial gro...

Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial gro...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71835969

Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor

About this item

Full title

Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor

Publisher

Germany: Springer Nature B.V

Journal title

Basic research in cardiology, 2004-05, Vol.99 (3), p.165-172

Language

English

Formats

Publication information

Publisher

Germany: Springer Nature B.V

More information

Scope and Contents

Contents

No prior study has examined the effect of intravenous injection of bone marrow mononuclear cells (MNCs) on myocardial infarction size (IS). We tested the hypothesis that transplantation of MNCs decreases IS through the release of vascular endothelial growth factor (VEGF). Immediately after ligation of the left coronary artery of immunodeficient mic...

Alternative Titles

Full title

Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_71835969

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71835969

Other Identifiers

ISSN

0300-8428

E-ISSN

1435-1803

DOI

10.1007/s00395-004-0456-9

How to access this item